The role of biomarkers in low respiratory tract infections
The role of biomarkers in low respiratory tract infections
Low respiratory tract infections (LRTI) represent the leading infectious cause of death worldwide and account for substantial use of healthcare resources. Physicians must adopt practices focused on improving outcomes and serum biomarker can help them in the management of patients with LRTI. Several studies have been carried out or are currently ongoing to evaluate the role of various biomarkers for the differential diagnosis, definition of prognosis, treatment and duration of antibiotic therapy in respiratory infections. The objective of this position paper of the Italian Society of Respiratory Diseases (SIMER) is to provide evidence-based recommendations for the use of biomarkers in routine clinical practice in the management of adult patients with LRTI. These guidelines capture the use of biomarkers both outside and inside the hospital, focused on community-acquired pneumonia, acute exacerbations of chronic obstructive pulmonary disease, hospital-acquired and ventilator-acquired pneumonia.
429-435
Blasi, Francesco
5758c460-00f5-4c63-bada-e2b50b47a625
Bocchino, Marialuisa
4577a14e-ba22-481f-ae86-be10a4647015
Di Marco, Fabiano
6813fac7-86ab-4e8e-b942-43d5ffed18d1
Richeldi, Luca
47177d9c-731a-49a1-9cc6-4ac8f6bbbf26
Aliberti, Stefano
8b7ad3e6-3ea7-4db1-9bf3-3cd494327d6a
July 2012
Blasi, Francesco
5758c460-00f5-4c63-bada-e2b50b47a625
Bocchino, Marialuisa
4577a14e-ba22-481f-ae86-be10a4647015
Di Marco, Fabiano
6813fac7-86ab-4e8e-b942-43d5ffed18d1
Richeldi, Luca
47177d9c-731a-49a1-9cc6-4ac8f6bbbf26
Aliberti, Stefano
8b7ad3e6-3ea7-4db1-9bf3-3cd494327d6a
Blasi, Francesco, Bocchino, Marialuisa, Di Marco, Fabiano, Richeldi, Luca and Aliberti, Stefano
(2012)
The role of biomarkers in low respiratory tract infections.
European Journal of Internal Medicine, 23 (5), .
(doi:10.1016/j.ejim.2012.05.002).
(PMID:22726371)
Abstract
Low respiratory tract infections (LRTI) represent the leading infectious cause of death worldwide and account for substantial use of healthcare resources. Physicians must adopt practices focused on improving outcomes and serum biomarker can help them in the management of patients with LRTI. Several studies have been carried out or are currently ongoing to evaluate the role of various biomarkers for the differential diagnosis, definition of prognosis, treatment and duration of antibiotic therapy in respiratory infections. The objective of this position paper of the Italian Society of Respiratory Diseases (SIMER) is to provide evidence-based recommendations for the use of biomarkers in routine clinical practice in the management of adult patients with LRTI. These guidelines capture the use of biomarkers both outside and inside the hospital, focused on community-acquired pneumonia, acute exacerbations of chronic obstructive pulmonary disease, hospital-acquired and ventilator-acquired pneumonia.
This record has no associated files available for download.
More information
Published date: July 2012
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 369082
URI: http://eprints.soton.ac.uk/id/eprint/369082
ISSN: 0953-6205
PURE UUID: c2c6de18-7434-4e50-894d-cb9d8feeba62
Catalogue record
Date deposited: 24 Sep 2014 11:48
Last modified: 27 Apr 2022 07:26
Export record
Altmetrics
Contributors
Author:
Francesco Blasi
Author:
Marialuisa Bocchino
Author:
Fabiano Di Marco
Author:
Luca Richeldi
Author:
Stefano Aliberti
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics